{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:11Z","timestamp":1788872411066,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":725,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Doctoral Research Fund of Dali University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jmii.2012.11.005","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T08:46:11Z","timestamp":1359189971000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6"],"prefix":"10.1016","volume":"47","author":[{"given":"Yi-Hao","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Si","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2012.11.005_bib1","series-title":"Global tuberculosis control: a short update to the 2011 report","year":"2011"},{"key":"10.1016\/j.jmii.2012.11.005_bib2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1126\/science.1184784","article-title":"Tuberculosis: what we don't know can, and does, hurt us","volume":"328","author":"Russell","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jmii.2012.11.005_bib3","first-page":"70","article-title":"The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy","volume":"48","author":"Zodpey","year":"2004","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.jmii.2012.11.005_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.vaccine.2011.12.059","article-title":"Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB\/c mice","volume":"30","author":"Christy","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2012.11.005_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/563838","article-title":"Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jmii.2012.11.005_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/IAI.05526-11","article-title":"Live attenuated salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis","volume":"80","author":"Juarez-Rodriguez","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib7","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2012.11.005_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-3083.2011.02604.x","article-title":"Cellular immune responses in mice induced by M. tuberculosis PE35-DNA vaccine construct","volume":"74","author":"Hanif","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jmii.2012.11.005_bib9","first-page":"1220","article-title":"Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guerin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice","volume":"120","author":"Wang","year":"2007","journal-title":"Chin Med (Engl)"},{"key":"10.1016\/j.jmii.2012.11.005_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","article-title":"Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG","volume":"64","author":"Harboe","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002378","article-title":"Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner","volume":"7","author":"Chatterjee","year":"2011","journal-title":"PloS Pathog"},{"key":"10.1016\/j.jmii.2012.11.005_bib12","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1128\/IAI.00793-08","article-title":"Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria","volume":"76","author":"Ciabattini","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib13","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2012.11.005_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-cell epitopes of Mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"D'Souza","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/IAI.74.1.202-212.2006","article-title":"Members of the 30- to 32-kilodalton mycolyl transferase family (Ag85) from culture filtrate of Mycobacterium avium subsp. paratuberculosis are immunodominant Th1-type antigens recognized early upon infection in mice and cattle","volume":"74","author":"Rosseels","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2006.00087.x","article-title":"Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration","volume":"47","author":"Giri","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jmii.2012.11.005_bib17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/IAI.68.2.767-778.2000","article-title":"Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages","volume":"68","author":"Armitige","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-3083.2010.02444.x","article-title":"Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Gu\u00e9rin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis","volume":"72","author":"Deng","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jmii.2012.11.005_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1348-0421.2011.00376.x","article-title":"Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and early secretory antigen target-6 fusion protein","volume":"55","author":"Deng","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jmii.2012.11.005_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00436-010-2130-5","article-title":"Immunogenicity and in\u00a0vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum","volume":"108","author":"Nurul","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.jmii.2012.11.005_bib21","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2012.11.005_bib22","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmii.2012.11.005_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030186","article-title":"Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes","volume":"3","author":"Davis","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jmii.2012.11.005_bib24","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1073\/pnas.94.10.5243","article-title":"Identification of nitric oxide synthase as a protective locus against tuberculosis","volume":"94","author":"MacMicking","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmii.2012.11.005_bib25","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/IAI.69.4.2666-2674.2001","article-title":"Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis","volume":"69","author":"Chackerian","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.jmii.2012.11.005_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027972","article-title":"Interactions between na\u00efve and infected macrophages reduce Mycobacterium tuberculosis viability","volume":"6","author":"Hartman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2012.11.005_bib27","doi-asserted-by":"crossref","first-page":"33953","DOI":"10.1074\/jbc.M503515200","article-title":"Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity","volume":"280","author":"Brodin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmii.2012.11.005_bib28","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.4049\/jimmunol.0803579","article-title":"ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis responsive human T cells","volume":"182","author":"Wang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jmii.2012.11.005_bib29","doi-asserted-by":"crossref","first-page":"24508","DOI":"10.1074\/jbc.M111.234062","article-title":"The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-gamma production through the P38 mitogen-activated protein kinase pathway","volume":"286","author":"Peng","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmii.2012.11.005_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2008.09.008","article-title":"Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis","volume":"89","author":"Sugawara","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jmii.2012.11.005_bib31","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1016\/j.vaccine.2010.07.087","article-title":"Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination","volume":"28","author":"Clark","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jmii.2012.11.005_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013773","article-title":"Protective efficacy of BCG over-expressing an L, D-transpeptidase against M. tuberculosis infection","volume":"5","author":"Nolan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2012.11.005_bib33","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-Rodal","year":"2006","journal-title":"Infect Immun"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821200240X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821200240X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:18:16Z","timestamp":1761657496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411821200240X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S168411821200240X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2012.11.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2012.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}